#YonhapInfomax #DaewoongPharmaceutical #Garcinia #AcuteHepatitis #MFDS #ProductRecall #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=83027
Daewoong Pharmaceutical Faces Regulatory Action Over 'Garcinia' Acute Hepatitis Cases—Company Disputes Food and Drug Safety Ministry's Decision
Daewoong Pharmaceutical disputes a recall order by South Korea’s drug regulator after two acute hepatitis cases linked to its Garcinia supplement, citing alcohol as a confounding factor and calling for a review of ingredient safety.


